Joint Diseases Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025
- Transparency Market Research
Joint disease is defined as any type of injury or inflammation or disease that affects human joints. Diseases of the joints could vary from acute to exceedingly chronic, unbearably painful or simply nagging and uncomfortable. It may be confined to one joint or may affect other parts of the skeleton. It can develop at any age; however, joint diseases are more prevalent in people aged between 40 and 65. Generally, women are at higher risk of developing joint diseases than men. However, it may vary with the type of joint disease. Joint diseases can be categorized into inflammatory joint disease, non-inflammatory joint diseases, and others. In inflammatory joint disease, inflammation is principal set of symptom while in non-inflammatory joint disease, inflammation may present to some extent but it is not essential feature. Other joint diseases include congenital or hereditary abnormalities and secondary joint diseases (such as tumors of joints). Inflammatory joint diseases include bursitis, infectious arthritis, rheumatoid arthritis & allied disorders, collagen disease, and others. Non-inflammatory joint diseases include, traumatic joint diseases, and degenerative joint diseases. Treatment of joint diseases depend upon the cause and joint affected. Usually, treatment of joint diseases start with RICE (Rest, Ice, Compression, and Elevation) followed by conventional therapy, biologics, and sometimes surgery.
The global joint diseases market can be segmented based on joint disease type, treatment, and region. In terms of joint disease type, the global market can be categorized into inflammatory joint disease, non-inflammatory joint disease, and others. Based on treatment, the global joint diseases market can be classified into medication (non-steroidal anti-inflammatory drugs, analgesic, steroids, biologic therapy, and immunosuppressive drug), therapy (physiotherapy and hydrotherapy), and surgery (joint replacement surgery). Rise in incidence and prevalence of various joint diseases, increased research and development expenditure, growing awareness among people, surge in geriatric population, and high number of joint injuries contribute to the growth of the global joint diseases market. However, currently available therapeutic options are effective at managing and preventing joint disease progression, the challenges of treating the joint diseases lie in the unpredictable responses of each patient, representing one of the biggest unmet needs in the global joint diseases market.
Geographically, the global joint diseases market can be segmented into five regions: North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is anticipated to dominate the market, followed by Europe. High incidence of joint diseases, rise in geriatric population, growing awareness among people, surge in research and development expenditure, strong clinical pipeline, and well-established health care infrastructure propel the joint diseases market in North America. The market in Asia Pacific is anticipated to expand at a high CAGR during the forecast period. This is attributed to large patient base, increase in government initiatives, and developing health care infrastructure in India and China. The market in Latin America and Middle East & Africa is anticipated to grow during the forecast period, owing to rise in investments by key players in these regions and increase in prevalence of joint diseases.
Leading players in the global joint diseases market include AbbVie, Pfizer Inc., Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., GlaxoSmithKline, AstraZeneca plc, Astellas Pharma, Johnson and Johnson, Amgen, Novartis International AG, Sanofi SA, and Daiiachi Sankyo.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Pharmaceutical
PharmaceuticalChinese Markets for Mental Illness Drugs
PharmaceuticalChinese Markets for Anti-Dermatomycosis Skin Drugs
PharmaceuticalChinese Markets for Incretion Drugs
PharmaceuticalChinese Markets for Hypertension Drugs
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017